Concepedia

Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease

Alistair Murray, Swe Mar Linn, Benoit Yu, Igor Novitzky‐Basso, Jonas Mattsson, Michael Kennah, Mohamed Elemary, Jennifer White, Christopher Lemieux, Kareem Jamani,

Bone Marrow Transplantation · 2024 · 11 citations · 15 references

DOI

Concepts

References

15

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Andrew C. Harris, Rachel Young, Steven M. Devine et al. · Biology of Blood and Marrow Transplantation · 2015 · 960 citations · Full text

, , +11

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

Robert Zeiser, Nikolas von Bubnoff, Jason Butler et al. · New England Journal of Medicine · 2020 · 865 citations · Full text

, , +17

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Robert Zeiser, Andreas Burchert, Claudia Lengerke et al. · Leukemia · 2015 · 540 citations · Full text

, , +16

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems

Margaret L. MacMillan, Daniel J. Weisdorf, John E. Wagner et al. · Biology of Blood and Marrow Transplantation · 2002 · 412 citations · Full text

, , +16

Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease

Silvia Spoerl, Nimitha R. Mathew, Michael Bscheider et al. · Blood · 2014 · 394 citations

, , +14